Skip to content

The Difference in Duration of Sciatic Nerve Block Between Diabetic and Non-diabetic Patients

The Difference in Duration of Sciatic Nerve Block Between Diabetic and Non-diabetic Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02482831
Acronym
DSNBD
Enrollment
53
Registered
2015-06-26
Start date
2014-09-30
Completion date
2015-08-31
Last updated
2015-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatic Nerve Block

Keywords

Sciatic nerve block, block duration, Semmes Weinstein monofilaments, fasting blood glucose, nerve block, sensory block duration, motor block duration

Brief summary

This study aims to compare the sensory and motor block duration and the incidence of nerve injury after sciatic nerve block between diabetic and non-diabetic patients, and screen for the factors that may affect the block recovery.

Detailed description

This is an observational study. All participants who experienced unilateral lower limb surgery and received an ultrasound-guided (nerve stimulator assisted) subgluteal sciatic nerve block with 0.75% ropivacaine 20ml in Peking Union Medical College Hospital were selected. They were further assigned to either diabetic group or non-diabetic group according to their medical history (primary exposure). The primary end point was the sensory and motor block duration. These durations in terms of sensory and motor blocks of sciatic nerve(dorsal side, plantar side) were assessed at baseline, every 2 hours in 48 hours after the block (except for the second night). In addition, the associations between fasting blood glucose, glycosylated hemoglobin (hemoglobin A1c, HbA1c) and the degree of diabetic retinopathy and the durations of sensory and motor block were also examined. This is not a intervention study, because we will examine the outcomes between diabetic or non-diabetic patients.

Interventions

All patients (either diabetic or non-diabetic patients) received an ultrasound-guided (nerve stimulator assisted) subgluteal sciatic nerve block with 0.75% ropivacaine 20ml.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists :I-III; * Age\>=18 years; * Undergo unilateral lower limb surgery; * Sign consent form.

Exclusion criteria

* Refuse regional Anesthesia; * Thresh of sensory \>10g; * Dyskinesia; * Bleeding disorder; * Regional skin infection; * Regional drug allergy; * Renal disfunction; * Incompliant to study; * Drug abuse.

Design outcomes

Primary

MeasureTime frameDescription
Duration of sensory block48 hoursSensory block is measured by Semmes Weinstein monofilaments. The block is measured at baseline, and every 2hours in 48 hours after the block.
Duration of motor block48 hoursMotor blocks is visualized. The block is measured at baseline, and every 2hours in 48 hours after the block

Countries

China

Contacts

Primary ContactShuai Tang, MD
tangshuai@pumch.cn13718754540

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026